Search results
What Is Anemia in Dogs, and How Can You Help Your Pup if They Have It?
Daily Paws via Yahoo News· 1 year agoJustin Paget / Getty TABLE OF CONTENTS On This Page What Is Anemia in Dogs? Causes and Types Signs...
A Twitter user claims GPT-4 saved his dog's life after a vet couldn't correctly diagnose her...
Business Insider via Yahoo Finance· 1 year agoA Twitter user named Cooper claims GPT-4 saved his border collie's life after a veterinarian...
Intravenous Immunoglobulin (IVIG) Therapy: How It Works and What to Expect
Verywell Health via Yahoo News· 6 days agoIntravenous Immunoglobulin (IVIG) therapy is a biologic treatment used for immunodeficiencies,...
Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug
Zacks via Yahoo Finance· 6 months agoNovartis NVS announced that the FDA approved iptacopan as the first oral monotherapy for the...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2022 Earnings Call Transcript March 23, 2023 Operator:...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 1 month agoThe first-quarter 2024 earnings season picked up pace this week, with Merck MRK, Sanofi SNY,...
Why Shares of Omeros Dropped on Monday
Motley Fool· 11 months agoShares of Omeros (NASDAQ: OMER) were down 12.9% early Monday afternoon after the clinical-stage biopharmaceutical company released a presentation it made...
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
Zacks via Yahoo Finance· 1 month agoSanofi's (SNY) BTK inhibitor, rilzabrutinib, demonstrates durable platelet response in the phase III...
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
Zacks via Yahoo Finance· 6 months agoThis week, AbbVie ABBV announced a definitive agreement to acquire neuroscience drugmaker Cerevel...
Roche (RHHBY) Announces Positive Results From PNH Studies
Zacks via Yahoo Finance· 11 months agoRoche (RHHBY) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in...
